These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29031417)

  • 1. [Skin pigmentation induced by meropenem and levofloxacin].
    Garval E; Vuiblet V; Durlach A; Perceau G; Anuset D; Bernard P
    Ann Dermatol Venereol; 2017 Dec; 144(12):793-798. PubMed ID: 29031417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brown-gray hyperpigmentation in a photosensitive distribution after levofloxacin exposure.
    Connors TM; Restrepo A; Dao H
    Dermatol Online J; 2018 Jul; 24(7):. PubMed ID: 30261569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucocutaneous Hyperpigmentation in a Patient With a History of Both Minocycline and Silver Ingestion.
    Fernandez-Flores A; Nguyen T; Cassarino DS
    Am J Dermatopathol; 2017 Dec; 39(12):916-919. PubMed ID: 28475520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new type of minocycline-induced cutaneous hyperpigmentation.
    Mouton RW; Jordaan HF; Schneider JW
    Clin Exp Dermatol; 2004 Jan; 29(1):8-14. PubMed ID: 14723711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline-induced hyperpigmentation in multibacillary leprosy.
    Hu SW; Robinson MR; Newlove T; Meehan S; Levis WR; Patel RR
    Am J Dermatopathol; 2012 Dec; 34(8):e114-8. PubMed ID: 23169418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous hyperpigmentation induced by doxycycline: histochemical and ultrastructural examination, laser microprobe mass analysis, and cathodoluminescence.
    Böhm M; Schmidt PF; Lödding B; Uphoff H; Westermann G; Luger TA; Bonsmann G; Metze D
    Am J Dermatopathol; 2002 Aug; 24(4):345-50. PubMed ID: 12142617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Minocycline-induced hyperpigmentation].
    Karrer S; Szeimies RM; Pfau A; Schröder J; Stolz W; Landthaler M
    Hautarzt; 1998 Mar; 49(3):219-23. PubMed ID: 9565791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of daily dosage and frequency of administration of rifampicin-levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections.
    Nguyen S; Robineau O; Titecat M; Blondiaux N; Valette M; Loiez C; Beltrand E; Migaud H; Senneville E
    Eur J Clin Microbiol Infect Dis; 2015 Aug; 34(8):1675-82. PubMed ID: 25987246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Element-specific analysis of a hyperpigmentation caused by levofloxacin therapy.
    Dinkel G; Kofler L; Sönnichsen K; Fehrenbacher B; Metzler G; Schaller M
    J Dtsch Dermatol Ges; 2017 Sep; 15(9):949-951. PubMed ID: 28872234
    [No Abstract]   [Full Text] [Related]  

  • 10. Levofloxacin-Induced Hyperpigmentation.
    Castellanos-González M; González Morales ML; González-Granda Villalobos J
    Actas Dermosifiliogr (Engl Ed); 2019 Oct; 110(8):700-701. PubMed ID: 31133294
    [No Abstract]   [Full Text] [Related]  

  • 11. Minocycline hyperpigmentation isolated to the subcutaneous fat.
    Rahman Z; Lazova R; Antaya RJ
    J Cutan Pathol; 2005 Aug; 32(7):516-9. PubMed ID: 16008698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline-induced skin pigmentation: an update.
    Geria AN; Tajirian AL; Kihiczak G; Schwartz RA
    Acta Dermatovenerol Croat; 2009; 17(2):123-6. PubMed ID: 19595269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline-induced hyperpigmentation in leprosy.
    Fleming CJ; Hunt MJ; Salisbury EL; McCarthy SW; Barnetson RS
    Br J Dermatol; 1996 Apr; 134(4):784-7. PubMed ID: 8733393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histopathology of subcutaneous minocycline pigmentation.
    Bowen AR; McCalmont TH
    J Am Acad Dermatol; 2007 Nov; 57(5):836-9. PubMed ID: 17939935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser.
    Alster TS; Gupta SN
    Dermatol Surg; 2004 Sep; 30(9):1201-4. PubMed ID: 15355359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The overlap Stevens-Johnson syndrome due to meropenem administration. Clinical case and nursing care].
    Rossi E
    Assist Inferm Ric; 2024; 43(2):83-90. PubMed ID: 38873717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Facial pigmentation following therapy with terbinafine].
    Breuer K; Völker B; Gutzmer R; Kapp A; Werfel T
    Hautarzt; 2005 Nov; 56(11):1056-9. PubMed ID: 15657730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DRESS Syndrome Following Levofloxacin Exposure With Positive Patch-test.
    Charfi O; Lakhoua G; Sahnoun R; Badri T; Daghfous R; El Aidli S; Kastalli S; Zaïem A
    Therapie; 2015; 70(6):547-9. PubMed ID: 26238129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amitriptyline-induced cutaneous hyperpigmentation: case report and review of psychotropic drug-associated mucocutaneous hyperpigmentation.
    Eichenfield DZ; Cohen PR
    Dermatol Online J; 2016 Feb; 22(2):. PubMed ID: 27267189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipramine-induced facial pigmentation: case report and literature review.
    Metelitsa AI; Nguyen GK; Lin AN
    J Cutan Med Surg; 2005 Dec; 9(6):341-5. PubMed ID: 17016757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.